Search

Your search keyword '"Brunet, Corinne"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Brunet, Corinne" Remove constraint Author: "Brunet, Corinne"
124 results on '"Brunet, Corinne"'

Search Results

5. Characterization of the novel Sezary lymphoma cell line BKP1

7. Formation sur la naloxone en clinique de médecine familiale, une mesure prometteuse

9. Mathematical modeling of peripheral blood neutrophil kinetics to predict CLAD after lung transplantation

10. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non‐Hodgkin lymphoma

11. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma

13. Depletion of memory B cells is effective to prevent relapses in AQP4 antibody NMOSD but not in MOG antibody disorder

15. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non‐Hodgkin lymphoma.

18. Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone

20. Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.

21. Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

22. Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: results from a bicentric study (P6.389)

23. Sepsis 2016 Paris

24. Sepsis 2016 Paris : Paris, France. 6-8 December 2016

25. Sepsis 2016 Paris: Paris, France. 6-8 December 2016

26. Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies

27. Impact of cART on CD8+T cell senescence: the ANRS EP45-aging study

28. Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

30. Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

32. Characterization of the novel Sezary lymphoma cell line BKP1

35. Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

36. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.

37. Tacrolimus/Mycophenolate Mofetil Improved Natural Killer Lymphocyte Reconstitution One Year After Kidney Transplant by Reference to Cyclosporine/Azathioprine

38. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions

45. Foxp3+ CD4+ CD25+ regulatory T cells are increased in patients with Coxiella burnetii endocarditis.

46. Sepsis 2016 Paris

47. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia

50. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.

Catalog

Books, media, physical & digital resources